If you require further searching capabilities for announcements please email: data@nzx.com
NZX and Media Release 19 October 2018 NZX Limited WELLINGTON Appointment of Alternate Director Cervical cancer technology company, TruScreen Ltd (NZAX, TRU), advises that the Board has consented to the appointment of Mr William Hunter to act as alternate Director for Mr Robert Hunter when he is unavailable to act. William is a business graduate from UTS (Sydney), a practising Charted Accountant in Australia and is currently undertaking post graduate studies in finance. He has considerable experience in a range of professional disciplines including financial planning, wealth management, superannuation and corporate advice. William also has a sound knowledge of the business operations of TruScreen. ENDS For more information visit www.TruScreen.com or contact: Tony Ho TruScreen Chairman Email: tonyho@truscreen.com Media Liaison Jackie Ellis Email: jackie@ellisandco.co.nz Phone: +64 27 246 2505 About TruScreen: Watch our video on TruScreen http://truscreen.com/truscreen-the-company/truscreen-ultra-video/ TruScreen's real time cervical cancer technology utilises a digital wand which is placed on the surface of the cervix to measure electrical and optical signals from the surrounding tissue. A sophisticated proprietary algorithm framework distinguishes between normal and abnormal (cancerous and precancerous) tissue to identify precancerous change, or cervical intraepithelial neoplasia (CIN). A Single Use Sensor (SUS) is used for each patient to protect against cross-infection. For more information, visit our website at www.truscreen.com End CA:00325578 For:TRU Type:ADMIN Time:2018-10-19 14:31:30